A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro to Humalog® in Healthy Subjects
NCT03604575 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28
Last updated 2018-07-27
Summary
Pharmacokinetics and pharmacodynamics study Study of 2 formulation of insulin lispro (Insulin Lispro GEROPHARM vers. Humalog® Eli Lilly)
Conditions
- Clamp Study
Interventions
- DRUG
-
Insulin Lispro
- DRUG
-
Humalog®
Sponsors & Collaborators
-
Geropharm
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-08-22
- Primary Completion
- 2016-12-26
- Completion
- 2016-12-26
Countries
- Russia
Study Locations
More Related Trials
-
Comparative Study of the Pharmacokinetics of Rinsulin® Mix 30/70, Suspension for Subcutaneous Administration, 100 IU / ml (OJSC GEROPHARM-Bio, Russia) and Humulin® M3, Suspension for Subcutaneous Administration, 100 IU / ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method
NCT04498884 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients
NCT04079413 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants
NCT03286751 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method
NCT04501250 ·Status: COMPLETED ·Phase: NA
-
An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects
NCT02660502 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 Diabetes
NCT02273258 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Insulin Rinsulin® NPH Compared to Humulin® NPH in Type 2 Diabetes Mellitus Patients
NCT04012775 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM)
NCT03341312 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type 1 Diabetes
NCT03903016 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacokinetics and Pharmacodynamics Between HR011408 and NovoRapid® in Healthy Subject
NCT05737576 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Demonstrate Pharmacokinetic and Pharmacodynamic Biosimilarity Between HEC-Glargine and US-Lantus® in Healthy Male Volunteers
NCT05248841 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics of Julphar Insulin R and Huminsulin® Normal
NCT02634515 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus
NCT03202875 ·Status: COMPLETED ·Phase: PHASE1
-
Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment
NCT01336751 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DM
NCT01357603 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Compare BioChaperone Insulin Lispro Formulations With US Approved Humalog® and With EU Approved Humalog® in Patients With Type 1 Diabetes Mellitus
NCT04501107 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Mellitus
NCT03341299 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY900014 in Participants With Type 1 Diabetes Mellitus
NCT03465878 ·Status: COMPLETED ·Phase: PHASE1
-
Insulin Glargine in Type 2 Diabetes Mellitus
NCT00311818 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30
NCT04022291 ·Status: COMPLETED ·Phase: PHASE1
-
Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers
NCT00969592 ·Status: COMPLETED ·Phase: PHASE1
-
Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes Mellitus
NCT01838083 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Insulin RinGlar® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients
NCT04022993 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Different Insulin Dosing Algorithms Using Hepatic Directed Vesicle-Insulin Lispro and Insulin Degludec
NCT03938740 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes
NCT03740919 ·Status: COMPLETED ·Phase: PHASE3